Paraneoplastic Sensory Neuropathy — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Sensory neuropathy
Non-length-dependent sensory neuronopathy (ganglionopathy) with anti-Hu antibodies in the context of SCLC (or breast cancer) is paraneoplastic sensory neuropathy. Unlike typical polyneuropathy, it affects cell bodies in the dorsal root ganglia producing asymmetric, non-length-dependent sensory loss. Painful dysaesthesias and sensory ataxia are characteristic.
Reference: PNS-Care 2024; eTG Neurology 2024